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Autophagy impairment has been implicated in several muscle dis-
orders and in age-related dysfunction. 
Although previous reports pointed to 
FOXO as a positive regulator of auto-
phagy in skeletal muscle, it remained 
unclear what is triggering autophagy. 
We found that TSC muscle knock-
out (TSCmKO) mice, characterized 
by specific depletion of TSC1 in skel-
etal muscle, and thus constant activa-
tion of MTORC1, develop a late-onset 
myopathy marked by the accumula-
tion of autophagic substrates. In those 
mice, autophagy induction is blocked 
despite FOXO activation because of 
constant MTORC1-dependent inhibi-
tion of ULK1. Treatment of TSCmKO 
mice with rapamycin is sufficient to 
restore autophagy and to alleviate, at 
least in part, the myopathy. Inversely, 
inactivation of the MTORC1 pathway in 
RPTOR-depleted muscles triggers LC3B 
lipidation in spite of FOXO inhibition. 
In conclusion, MTORC1 constitutes the 
master regulator of autophagy induction 
in skeletal muscle and its deregulation 
leads to pathologic alterations of muscle 
homeostasis.
Autophagy is an essential, catabolic pro-
cess that ensures the clearance of dam-
aged organelles and misfolded proteins. In 
most cell types, inhibition of MTORC1 
via fasting or administration of rapamy-
cin induces autophagy. Several lines of 
evidence indicate that this induction is 
based on the relief of MTORC1-mediated 
phosphorylation of ULK1 at Ser757 
and the subsequent activation of the 
ULK1-ATG13-RB1CC1/FIP200 com-
plex by AMPK. Previous reports showed 
that constitutively active FOXO3, but not 
rapamycin, induces autophagy in skel-
etal muscle, suggesting that in these cells 
autophagy is independent of MTORC1 
but instead is regulated by FOXO signal-
ing through the transcriptional regula-
tion of autophagy genes. However, the 
control of autophagy by FOXO would 
not allow instantaneous activation of 
the process, and the failure of rapamycin 
to induce autophagy in skeletal muscle 
might be based on insufficient inhibition 
of MTORC1.
To analyze the role of MTORC1 in 
autophagy regulation directly, we gen-
erated TSCmKO mice, which lack the 
main endogenous inhibitor of MTORC1 
in muscle. As expected, the immediate 
MTORC1 target RP6KB/ribosomal pro-
tein p70S6 kinase is constantly activated 
and, as a consequence of the negative feed-
back onto IRS1, the FOXO pathway is 
simultaneously activated in mutant mice. 
This unique configuration allowed testing 
the role of MTORC1 and FOXO path-
ways on autophagy as they are expected to 
have reciprocal effects on the flux. Exami-
nation of muscles from aging TSCmKO 
mice revealed accumulation of autophagic 
substrates and abnormal organelles. Con-
comitantly, muscles display a loss of mass 
and a reduction of force, indicating that 
autophagy impairment causes progressive 
myopathy in TSCmKO mice (Fig. 1).
To better understand these defects, 
2-mo-old TSCmKO mice were submit-
ted to starvation, which is a well-described 
trigger of autophagy. The first interesting 
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observation was that TSCmKO mice 
show permanently active MTORC1 sig-
naling irrespective of their feeding behav-
ior, which was further confirmed in vitro 
by incubating TSCmKO fibers in amino 
acid- and glucose-depleted medium. 
Hence, TSC1 depletion is sufficient to 
promote MTORC1 activation in muscle 
cells, independently from other stimuli. 
In TSCmKO muscle, it remains to be 
determined whether MTORC1, known 
to be activated by RHEB at the lysosome 
membrane, is targeted to this organelle in 
an amino acid-independent mechanism or 
whether its activation occurs at a different 
subcellular compartment.
Importantly, induction of autophagy is 
blocked in TSCmKO muscles even after 
prolonged starvation of the mice, as well 
as in vitro, when mutant muscle fibers 
are exposed to glucose- and amino acid-
depleted medium. The observed effects 
are not due to long-term adaptation of 
the muscle, as transient hyperactivation 
of MTORC1 using shRNA-mediated 
knockdown of TSC1/2 is sufficient to 
impair the autophagy flux. Since previous 
reports showed that expression of auto-
phagy genes, such as Map1lc3b (Lc3b) 
or Bnip3, is critical for autophagy, we 
verified that those genes are efficiently 
upregulated in mutant muscles, consistent 
with the activation of FOXO signaling. 
Instead, we established that this block-
ade was based on the strong increase in 
phospho-ULK1S757 as overexpression of 
nonphosphorylated ULK1 by muscle elec-
troporation is sufficient to activate auto-
phagy and thus to reverse the inhibitory 
effect of MTORC1 (Fig. 1). It remains to 
be tested whether other phosphorylation 
sites of ULK1 physiologically modulate its 
interaction with AMPK and MTORC1, 
and interfere with the stabilization of the 
ULK1-ATG13-RB1CC1 complex in mus-
cle cells.
Interestingly, treatment of TSC-
mKO mice with the MTORC1 inhibi-
tor rapamycin restores autophagy, and 
normalizes phosphorylation of ULK1 
at Ser757 becomes undetectable. Most 
importantly, 3 weeks treatment is also 
sufficient to reverse some of the myopa-
thy defects and to re-establish force in 
Figure 1. in physiological conditions, the activity of the AKt/mtoRc1 axis depends on feeding behavior and varies within the day (top panel). in the 
fed state, mtoRc1 blocks the induction of autophagy through phosphorylation of uLK1 at Ser757. constitutive autophagy involved in basal turnover of 
organelles and proteins is induced upon the release of mtoRc1-dependent inhibition of the uLK1 complex (lower panel). During starvation, activation 
of the AmpK/FoXo axis promotes transcription of autophagy genes and ensures higher, prolonged autophagy flux required to maintain cell homeo-
stasis. in tScmKo muscles, mtoRc1 is active irrespective of other stimuli and constantly inhibits autophagy induction (left panel). conversely, mtoRc1 
inactivation in RAmKo muscles facilitates permanent induction of the flux, whereas FoXo inactivation may limit the degradation steps (right panel). in 
these two mouse models, impaired autophagy flux is likely involved in the atrophy of most muscles and the onset of the myopathy.
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12-mo-old mutant mice. The possibil-
ity to alleviate the muscle phenotype of 
aged TSCmKO mice by inhibiting the 
MTORC1 pathway was unexpected to 
say the least and this observation raises 
the interesting question as to the mecha-
nisms involved in the fast removal of those 
autophagy-related muscle alterations, 
including vacuoles and protein aggregates.
Last, to test the consequences of the 
simultaneous inactivation of MTORC1 
and FOXO pathways on autophagy, we 
also examined RAmKO mice, which are 
depleted for RPTOR in adult skeletal 
muscle. In those mice, autophagy is per-
manently induced, even in fed conditions. 
Expression of autophagy-related genes, 
although slightly increased upon starva-
tion, remains strongly reduced indicating 
that the increased autophagy induction 
occurs independently from FOXO inhi-
bition (Fig. 1). Nonetheless, the scaffold 
molecule SQSTM1/p62, ubiquitinated 
proteins and LAMP-positive structures 
accumulate in muscle from 6-mo-old 
RAmKO mice. These features are indica-
tive of an impaired processing of the flux, 
which may be related to the inactivation 
of FOXO signaling: one possibility might 
be that degradation steps are impaired, 
as expression of the lysosomal protease 
CTSL/cathepsin L is barely detectable in 
RAmKO muscles. This aspect requires 
more detailed investigation to dissect the 
origin of the defects and the potential 
involvement of FOXO inhibition.
In conclusion, on the one hand the 
work establishes that MTORC1 plays a 
dominant role in controlling the induc-
tion of autophagy in skeletal muscle. 
Both exaggerated activation and inhibi-
tion of MTORC1 affect proper, balanced 
autophagy flux and are thus detrimental 
for muscle homeostasis. Hence, modula-
tions of MTORC1 may be the trigger in 
altering autophagy flux during the day 
in a circadian manner (Fig. 1). On the 
other hand, the data also indicate that 
prolonged, sustained autophagy may rely 
on correct activation of FOXO signal-
ing. Based on these lines of evidence, one 
should reconsider the direct implication of 
MTORC1 in the pathogenesis of muscle 
disorders, such as collagen VI-myopathies, 
for which autophagy impairment has been 
related to AKT imbalance. Our study also 
opens new perspectives for the develop-
ment of therapeutic strategies targeting 
MTORC1 as a determinant element for 
autophagy regulation and muscle wasting. 
However, it also points out that major vig-
ilance has to be taken in the modulation 
of the pathway given that muscle homeo-
stasis appears to depend on a dynamic and 
balanced regulation of autophagy.
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